ロード中...
Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase‐5A inhibitor vardenafil in rats with type 2 diabetes
AIMS: Heart failure with preserved ejection fraction (HFpEF) has a great epidemiological burden. The pathophysiological role of cyclic guanosine monophosphate (cGMP) signalling has been intensively investigated in HFpEF. Elevated levels of cGMP have been shown to exert cardioprotective effects in va...
保存先:
| 出版年: | Eur J Heart Fail |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347963/ https://ncbi.nlm.nih.gov/pubmed/27995696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.711 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|